Show simple item record

dc.contributor.authorDemirkaya, Erkan
dc.contributor.authorOzen, Seza
dc.contributor.authorSozeri, Betul
dc.contributor.authorAyaz, Nuray Aktay
dc.contributor.authorKasapcopur, Ozgur
dc.contributor.authorUnsal, Erbil
dc.contributor.authorMakay, Balahan Bora
dc.contributor.authorBarut, Kenan
dc.contributor.authorFidanci, Berna Eren
dc.contributor.authorSimsek, Dogan
dc.contributor.authorCakan, Mustafa
dc.contributor.authorConsolaro, Alessandro
dc.contributor.authorBovis, Francesca
dc.contributor.authorRuperto, Nicolino
dc.date.accessioned2019-12-10T11:21:00Z
dc.date.available2019-12-10T11:21:00Z
dc.date.issued2018
dc.identifier.issn0172-8172
dc.identifier.urihttps://doi.org/10.1007/s00296-018-3982-8
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893710/
dc.identifier.urihttp://hdl.handle.net/11655/15416
dc.description.abstractThe Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Turkish language. The reading comprehension of the questionnaire was tested in 10 JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the 3 Likert assumptions, floor/ceiling effects, internal consistency, Cronbach’s alpha, interscale correlations, test–retest reliability, and construct validity (convergent and discriminant validity). A total of 466 JIA patients (13.7% systemic, 40.6% oligoarticular, 22.5% RF negative poly-arthritis, and 23.2% other categories) and 93 healthy children were enrolled in four centres. The JAMAR components discriminated well-healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Turkish version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.
dc.relation.isversionof10.1007/s00296-018-3982-8
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleThe Turkish Version Of The Juvenile Arthritis Multidimensional Assessment Report (Jamar)
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalRheumatology International
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume38
dc.identifier.issueSuppl 1
dc.identifier.startpage395
dc.identifier.endpage402
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Files in this item

This item appears in the following Collection(s)

Show simple item record